Daiwa Securities Group’s Quest Diagnostics DGX Stock Holding History

Daiwa Securities Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.24M	Buy	20,027 +1,104	+6%	+$217K	0.01%	546
2026 Q1	$3.71M	Buy	18,923 +818	+5%	+$159K	0.01%	528
2025 Q4	$3.14M	Buy	18,105 +564	+3%	+$103K	0.01%	558
2025 Q3	$3.34M	Sell	17,541 -1,058	-6%	-$188K	0.01%	529
2025 Q2	$3.34M	Buy	18,599 +2,718	+17%	+$472K	0.01%	512
2025 Q1	$2.69M	Buy	15,881 +1,130	+8%	+$186K	0.01%	529
2024 Q4	$2.23M	Buy	14,751 +1,059	+8%	+$165K	0.01%	567
2024 Q3	$2.13M	Buy	13,692 +1,569	+13%	+$234K	0.01%	571
2024 Q2	$1.66M	Buy	12,123 +1,011	+9%	+$138K	0.01%	603
2024 Q1	$1.48M	Buy	11,112 +1,042	+10%	+$135K	0.01%	630
2023 Q4	$1.39M	Buy	10,070 +664	+7%	+$87.3K	0.01%	612
2023 Q3	$1.15M	Buy	9,406 +564	+6%	+$75.1K	0.01%	638
2023 Q2	$1.24M	Buy	8,842 +249	+3%	+$34.3K	0.01%	612
2023 Q1	$1.22M	Buy	8,593 +371	+5%	+$53.1K	0.01%	610
2022 Q4	$1.29M	Buy	8,222 +285	+4%	+$41K	0.01%	578
2022 Q3	$974K	Buy	7,937 +366	+5%	+$48.2K	0.01%	650
2022 Q2	$1.01M	Sell	7,571 -702	-8%	-$95.7K	0.01%	654
2022 Q1	$1.13M	Sell	8,273 -47	-0.6%	-$6.55K	0.01%	666
2021 Q4	$1.44M	Buy	8,320 +821	+11%	+$125K	0.01%	595
2021 Q3	$1.09M	Buy	7,499 +76	+1%	+$11.1K	0.01%	652
2021 Q2	$980K	Buy	7,423 +300	+4%	+$39.3K	0.01%	654
2021 Q1	$914K	Buy	7,123 +278	+4%	+$34.3K	0.01%	652
2020 Q4	$816K	Buy	6,845 +148	+2%	+$18K	0.01%	626
2020 Q3	$767K	Buy	6,697 +446	+7%	+$52.7K	0.01%	578
2020 Q2	$502K	Hold	6,251	–	–	0.01%	537
2020 Q1	$502K	Buy	6,251 +250	+4%	+$25.9K	0.01%	648
2019 Q4	$641K	Buy	6,001 +612	+11%	+$63.8K	0.01%	638
2019 Q3	$577K	Buy	5,389 +116	+2%	+$11.9K	﹤0.01%	639
2019 Q2	$537K	Hold	5,273	–	–	﹤0.01%	643
2019 Q1	$474K	Buy	5,273 +250	+5%	+$21.7K	﹤0.01%	662
2018 Q4	$418K	Hold	5,023	–	–	﹤0.01%	652
2018 Q3	$542K	Buy	5,023 +380	+8%	+$41.7K	﹤0.01%	631
2018 Q2	$510K	Hold	4,643	–	–	﹤0.01%	633
2018 Q1	$466K	Buy	4,643 +616	+15%	+$63.1K	﹤0.01%	639
2017 Q4	$397K	Sell	4,027 -3,249	-45%	-$308K	﹤0.01%	680
2017 Q3	$681K	Sell	7,276 -74	-1%	-$7.86K	﹤0.01%	518
2017 Q2	$817K	Buy	7,350 +150	+2%	+$15.9K	0.01%	478
2017 Q1	$707K	Buy	7,200 +3,300	+85%	+$315K	﹤0.01%	520
2016 Q4	$358K	Buy	3,900 +400	+11%	+$34.5K	﹤0.01%	619
2016 Q3	$296K	Buy	3,500 +200	+6%	+$16.8K	﹤0.01%	605
2016 Q2	$269K	Hold	3,300	–	–	﹤0.01%	607
2016 Q1	$236K	Hold	3,300	–	–	﹤0.01%	626
2015 Q4	$235K	Hold	3,300	–	–	﹤0.01%	634
2015 Q3	$203K	Hold	3,300	–	–	﹤0.01%	670
2015 Q2	$239K	Sell	3,300 -200	-6%	-$14.8K	﹤0.01%	673
2015 Q1	$269K	Hold	3,500	–	–	﹤0.01%	583
2014 Q4	$235K	Sell	3,500 -300	-8%	-$18.9K	﹤0.01%	589
2014 Q3	$231K	Hold	3,800	–	–	﹤0.01%	599
2014 Q2	$223K	Hold	3,800	–	–	﹤0.01%	623
2014 Q1	$220K	Sell	3,800 -400	-10%	-$21.4K	﹤0.01%	612
2013 Q4	$225K	Sell	4,200 -3,200	-43%	-$190K	﹤0.01%	614
2013 Q3	$457K	Buy	7,400 +600	+9%	+$35.9K	﹤0.01%	411
2013 Q2	$412K	Buy	+6,800	New	+$405K	﹤0.01%	462

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Daiwa Securities Group's DGX Position: Q2 2026 in Review

Daiwa Securities Group increased its Quest Diagnostics (DGX) stake by 5.8% in Q2 2026, buying an estimated $217K and bringing the position to 20,027 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #546.

Daiwa Securities Group first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Daiwa Securities Group held 20,027 shares of Quest Diagnostics worth $4.24M as of Q2 2026.
Daiwa Securities Group bought 1,104 Quest Diagnostics shares in Q2 2026, an estimated $217K.
Quest Diagnostics made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #546 holding.
Daiwa Securities Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.